Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Physician Assist Educ ; 29(2): 115-117, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29727432

RESUMEN

PURPOSE: To assess student perceptions of the use of the "Muddiest Point" as a type of formative classroom assessment technique (CAT) in a clinical skills laboratory course. METHODS: Physician assistant (PA) students enrolled in a private university were invited to complete a perception survey regarding the use of the Muddiest Point at the conclusion of the course. RESULTS: Survey results showed positive overall student perceptions of the Muddiest Point and desire for broader use of this CAT in other courses. CONCLUSIONS: The Muddiest Point is a CAT that is simple for the instructor to implement and showed overall perceived benefit to the PA student. The Muddiest Point is an effective method to gauge student learning and allows students to be active participants in their education.


Asunto(s)
Competencia Clínica , Evaluación Educacional/métodos , Percepción , Asistentes Médicos/educación , Estudiantes del Área de la Salud/psicología , Adulto , Actitud del Personal de Salud , Femenino , Humanos , Masculino , Adulto Joven
3.
World J Orthop ; 5(4): 504-11, 2014 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-25232526

RESUMEN

Tofacitinib is the first in a new class of nonbiologic disease-modifying antirheumatic drugs (DMARDs), a targeted, synthetic DMARD, approved for the treatment of rheumatoid arthritis (RA) as monotherapy or in combination with methotrexate or other non-biologic DMARD. Tofacitinib, an orally administered Janus kinase (JAK) inhibitor, decreases T-cell activation, pro-inflammatory cytokine production, and cytokine signaling by inhibiting binding of type I cytokine receptors family and γ-chain cytokines to paired JAK1/JAK3 receptors. The net effect of tofacitinb's mechanism of action is decreased synovial inflammation and structural joint damage in RA patients. To date, six phase 3 trials have been conducted to evaluate the safety and efficacy of tofacitinib under the oral rheumatoid arthritis triaLs (ORAL) series. This review describes the pharmacology of the novel agent, tofacitinib, and details the safety and efficacy data of the ORAL trials.

6.
PLoS One ; 8(2): e56793, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23437238

RESUMEN

SWI/SNF is a chromatin remodeling complex that affects transcription initiation and elongation by RNA polymerase II. Here we report that SWI/SNF also plays a role in transcription by RNA polymerase I (Pol I) in Saccharomyces cerevisiae. Deletion of the genes encoding the Snf6p or Snf5p subunits of SWI/SNF was lethal in combination with mutations that impair Pol I transcription initiation and elongation. SWI/SNF physically associated with ribosomal DNA (rDNA) within the coding region, with an apparent peak near the 5' end of the gene. In snf6Δ cells there was a ∼2.5-fold reduction in rRNA synthesis rate compared to WT, but there was no change in average polymerase occupancy per gene, the number of rDNA gene repeats, or the percentage of transcriptionally active rDNA genes. However, both ChIP and EM analyses showed a small but reproducible increase in Pol I density in a region near the 5' end of the gene. Based on these data, we conclude that SWI/SNF plays a positive role in Pol I transcription, potentially by modifying chromatin structure in the rDNA repeats. Our findings demonstrate that SWI/SNF influences the most robust transcription machinery in proliferating cells.


Asunto(s)
Ensamble y Desensamble de Cromatina , ARN Polimerasa I/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Transcripción Genética , ADN Ribosómico/metabolismo , Epistasis Genética , Eliminación de Gen , Dosificación de Gen , Regulación Fúngica de la Expresión Génica , Mutación , Unión Proteica , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , ARN Ribosómico/genética , ARN Ribosómico/metabolismo , Proteínas de Saccharomyces cerevisiae/genética
7.
J Biol Chem ; 286(21): 18816-24, 2011 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-21467039

RESUMEN

Spt5p is a universally conserved transcription factor that plays multiple roles in eukaryotic transcription elongation. Spt5p forms a heterodimer with Spt4p and collaborates with other transcription factors to pause or promote RNA polymerase II transcription elongation. We have shown previously that Spt4p and Spt5p also influence synthesis of ribosomal RNA by RNA polymerase (Pol) I; however, previous studies only characterized defects in Pol I transcription induced by deletion of SPT4. Here we describe two new, partially active mutations in SPT5 and use these mutant strains to characterize the effect of Spt5p on Pol I transcription. Genetic interactions between spt5 and rpa49Δ mutations together with measurements of ribosomal RNA synthesis rates, rDNA copy number, and Pol I occupancy of the rDNA demonstrate that Spt5p plays both positive and negative roles in transcription by Pol I. Electron microscopic analysis of mutant and WT strains confirms these observations and supports the model that Spt4/5 may contribute to pausing of RNA polymerase I early during transcription elongation but promotes transcription elongation downstream of the pause(s). These findings bolster the model that Spt5p and related homologues serve diverse critical roles in the control of transcription.


Asunto(s)
Proteínas Cromosómicas no Histona/metabolismo , Modelos Biológicos , ARN Polimerasa I/metabolismo , Saccharomyces cerevisiae/metabolismo , Transcripción Genética/fisiología , Factores de Elongación Transcripcional/metabolismo , Proteínas Cromosómicas no Histona/genética , ADN de Hongos/genética , ADN de Hongos/metabolismo , ADN Ribosómico/genética , ADN Ribosómico/metabolismo , Eliminación de Gen , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , ARN Polimerasa I/genética , ARN Polimerasa II/genética , ARN Polimerasa II/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Activación Transcripcional/fisiología , Factores de Elongación Transcripcional/genética
8.
Mol Cell Biol ; 31(3): 482-94, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21098118

RESUMEN

To better understand the role of topoisomerase activity in relieving transcription-induced supercoiling, yeast genes encoding rRNA were visualized in cells deficient for either or both of the two major topoisomerases. In the absence of both topoisomerase I (Top1) and topoisomerase II (Top2) activity, processivity was severely impaired and polymerases were unable to transcribe through the 6.7-kb gene. Loss of Top1 resulted in increased negative superhelical density (two to six times the normal value) in a significant subset of rRNA genes, as manifested by regions of DNA template melting. The observed DNA bubbles were not R-loops and did not block polymerase movement, since genes with DNA template melting showed no evidence of slowed elongation. Inactivation of Top2, however, resulted in characteristic signs of slowed elongation in rRNA genes, suggesting that Top2 alleviates transcription-induced positive supercoiling. Together, the data indicate that torsion in front of and behind transcribing polymerase I has different consequences and different resolution. Positive torsion in front of the polymerase induces supercoiling (writhe) and is largely resolved by Top2. Negative torsion behind the polymerase induces DNA strand separation and is largely resolved by Top1.


Asunto(s)
ADN-Topoisomerasas de Tipo II/metabolismo , ADN-Topoisomerasas de Tipo I/metabolismo , Genes de ARNr/genética , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/genética , Estrés Mecánico , Transcripción Genética , ADN Polimerasa I/metabolismo , Replicación del ADN/genética , Activación Enzimática , Genes Fúngicos/genética , Modelos Biológicos , Mutación/genética , Conformación de Ácido Nucleico , Desnaturalización de Ácido Nucleico , Ribonucleasa H/metabolismo , Saccharomyces cerevisiae/ultraestructura , Torsión Mecánica
9.
Proc Natl Acad Sci U S A ; 106(7): 2153-8, 2009 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-19164765

RESUMEN

Regulation of RNA polymerase I (Pol I) transcription is critical for controlling ribosome synthesis. Most previous investigations into Pol I transcription regulation have focused on transcription initiation. To date, the factors involved in the control of Pol I transcription elongation are poorly understood. The Paf1 complex (Paf1C) is a well-defined factor that influences polymerase II (Pol II) transcription elongation. We found that Paf1C associates with rDNA. Deletion of genes for Paf1C subunits (CDC73, CTR9, or PAF1) reduces the rRNA synthesis rate; however, there is no significant alteration of rDNA copy number or Pol I occupancy of the rDNA. Furthermore, EM analysis revealed a substantial increase in the frequency of large gaps between transcribing polymerases in ctr9Delta mutant cells compared with WT. Together, these data indicate that Paf1C promotes Pol I transcription through the rDNA by increasing the net rate of elongation. Thus, the multifunctional, conserved transcription factor Paf1C plays an important role in transcription elongation by Pol I in vivo.


Asunto(s)
Proteínas Nucleares/fisiología , Proteínas de Saccharomyces cerevisiae/fisiología , Transcripción Genética , Fenómenos Bioquímicos , ADN Polimerasa I/metabolismo , Cartilla de ADN/química , ADN Ribosómico/metabolismo , Eliminación de Gen , Regulación Fúngica de la Expresión Génica , Modelos Biológicos , Proteínas Nucleares/química , Plásmidos/metabolismo , ARN Polimerasa I/genética , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/química , Proteínas de Saccharomyces cerevisiae/genética
10.
Methods Mol Biol ; 464: 55-69, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-18951179

RESUMEN

The Miller chromatin spreading technique for electron microscopic visualization of gently dispersed interphase chromatin has proven extremely valuable for analysis of genetic activities in vivo. It provides a unique view of transcription and RNA processing at the level of individual active genes. The budding yeast Saccharomyces cerevisiae has also been an invaluable model system for geneticists and molecular biologists. In this chapter, we describe methods for applying the Miller chromatin-spreading method to Saccharomyces cerevisiae. This allows one to use electron microscopic visualization of a gene of interest to study effects of specific mutations on gene activity. We are applying the method to study transcription and processing of ribosomal RNA.


Asunto(s)
Cromatina/genética , Cromatina/ultraestructura , Microscopía Electrónica/métodos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/ultraestructura , Transcripción Genética/genética , Procesamiento Postranscripcional del ARN/genética , ARN Ribosómico/genética , ARN Ribosómico/ultraestructura
11.
Mol Cell Biol ; 28(14): 4576-87, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18474615

RESUMEN

5S rRNA genes from Saccharomyces cerevisiae were examined by Miller chromatin spreading, representing the first quantitative analysis of RNA polymerase III genes in situ by electron microscopy. These very short genes, approximately 132 nucleotides (nt), were engaged by one to three RNA polymerases. Analysis in different growth conditions and in strains with a fourfold range in gene copy number revealed regulation at two levels: number of active genes and polymerase loading per gene. Repressive growth conditions (presence of rapamycin or postexponential growth) led first to fewer active genes, followed by lower polymerase loading per active gene. The polymerase III elongation rate was estimated to be in the range of 60 to 75 nt/s, with a reinitiation interval of approximately 1.2 s. The yeast La protein, Lhp1, was associated with 5S genes. Its absence had no discernible effect on the amount or size of 5S RNA produced yet resulted in more polymerases per gene on average, consistent with a non-rate-limiting role for Lhp1 in a process such as polymerase release/recycling upon transcription termination.


Asunto(s)
ARN Ribosómico 5S/genética , Proteínas de Unión al ARN/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/genética , Transcripción Genética , ADN Espaciador Ribosómico/metabolismo , Genes Fúngicos , Genes de ARNr , ARN Polimerasa III/metabolismo , Saccharomyces cerevisiae/metabolismo
12.
Mol Cell ; 26(2): 217-29, 2007 Apr 27.
Artículo en Inglés | MEDLINE | ID: mdl-17466624

RESUMEN

The synthesis of ribosomes in eukaryotic cells is a complex process involving many nonribosomal protein factors and snoRNAs. In general, the processes of rRNA transcription and ribosome assembly are treated as temporally or spatially distinct. Here, we describe the identification of a point mutation in the second largest subunit of RNA polymerase I near the active center of the enzyme that results in an elongation-defective enzyme in the yeast Saccharomyces cerevisiae. In vivo, this mutant shows significant defects in rRNA processing and ribosome assembly. Taken together, these data suggest that transcription of rRNA by RNA polymerase I is linked to rRNA processing and maturation. Thus, RNA polymerase I, elongation factors, and rRNA sequence elements appear to function together to optimize transcription elongation, coordinating cotranscriptional interactions of many factors/snoRNAs with pre-rRNA for correct rRNA processing and ribosome assembly.


Asunto(s)
ARN Polimerasa I/metabolismo , ARN de Hongos/metabolismo , ARN Ribosómico/metabolismo , Saccharomyces cerevisiae/metabolismo , Genes Fúngicos , Mutación Puntual , Subunidades de Proteína , ARN Polimerasa I/química , ARN Polimerasa I/genética , Procesamiento Postranscripcional del ARN , Ribosomas/metabolismo , Saccharomyces cerevisiae/genética , Transcripción Genética
13.
Chromosoma ; 111(1): 1-12, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12068918

RESUMEN

Transcription termination by RNA polymerase II (Pol II) on most mRNA-encoding genes is dependent on transcription through a functional poly(A) signal. One model to explain this dependence predicts co-trancriptional cleavage of RNA at the poly(A) site. Electron microscopic (EM) visualization was used to investigate the in vivo frequency of transcript cleavage prior to termination. Over 100 unidentified Drosophila Pol II-transcribed genes were analyzed. Although some genes exhibited cleaved transcripts near their 3' ends, and some had a lower polymerase density at their 3' end relative to the rest of the gene, the majority of genes (64%) had uncleaved transcripts and no change in polymerase density at the 3' end, consistent with release of full-length transcripts at a discrete site. Thus, in Drosophila, cleavage at the poly(A) site sometimes occurs co-transcriptionally, but does not appear to be a prerequisite to termination. Next, two components of the polyadenylation complex were immunolocalized on polytene chromosomes and were found to differ in distribution both qualitatively and quantitatively. The EM results indicate that co-transcriptional recognition of the poly(A) signal, which is required for termination, does not equate with co-transcriptional cleavage, and the immunofluorescence results suggest that this may be due to incomplete or nonstoichiometric assembly of the polyadenylation machinery on nascent transcripts.


Asunto(s)
Drosophila/genética , ARN Polimerasa II/metabolismo , Adenosina/metabolismo , Animales , Cromosomas/ultraestructura , Drosophila/enzimología , Drosophila/ultraestructura , Técnica del Anticuerpo Fluorescente , Polímeros/metabolismo , ARN/ultraestructura , ARN Polimerasa II/ultraestructura , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...